Financing channel feed – Endpoints News

Financing channel feed

WuXi AppTec cruises toward a steady debut in Hong Kong stock exchange, ending flat on IPO price

7 years ago

Upstart Akero continues its swoosh into NASH space with $70M windfall round

7 years ago

Black Diamond turns down an open stretch of R&D highway, headed to a showdown with oncogenes

7 years ago

Sue Dillon, Karyn O'Neil steer fledgling Aro Biotherapeutics to $13M debut — with J&J's blessing

7 years ago

WuXi AppTec starts a global wave of expansion, jumping off in San Diego following $1B Hong Kong IPO raise

7 years ago

Nasdaq celebrates epic biotech IPO success in 2018. But can the party on Wall Street rumba on?

7 years ago

Moderna skirts the reefs of disaster and sails into Wall Street with a $604M IPO bounty — but shares slide

7 years ago

Seattle’s Impel NeuroPharma bags $67.5M crossover raise for a round of new drug/device CNS clinical trials

7 years ago

Forget Hong Kong, Grail is now going for a 2019 IPO in the US — Bloomberg

7 years ago

Roswell Park spinout raises $35M from Chinese investors to pursue one-two punch for adoptive T cell therapy

7 years ago

Prepping for key ASH presentation, little Aprea Therapeutics gets $57M to fuel PhIII p53 cancer study

7 years ago

After a long, hard slog to the clinic, stem cell player ViaCyte fuels up with $105M for its next big attack on diabetes

7 years ago

Can a $1B IPO attract leery investors on HKEX? WuXi AppTec is set to find out

7 years ago

The flip side of the hot IPO market? A chill could trigger a sudden cash crunch in biotech, followed by more deals

7 years ago

Founded by former Pharmasset, Idenix execs, hep B company Antios nabs $25M Series A

7 years ago

Can a biotech unicorn break into the record books with a $600M IPO? Stéphane Bancel has a fortune riding on the answer

7 years ago

Wellington, HBM lead €24M round as Adrenomed preps septic shock treatment for human testing

7 years ago

Global syndicate backs $400M genomics R&D play in Ireland as WuXi NextCODE extends its reach into Europe

7 years ago

Germany's Merck forges JV with Thiel's Palantir to harness data to attack cancer

7 years ago

Novartis-backed Inflazome raises $46M for their clinical challenge to prove NLRP3 is a great anti-inflammatory target

7 years ago

Seeking an edge in the global I/O race, Alphamab Oncology loads up $100M-plus from marquee backers

7 years ago

Genfit plans US listing as NASH drugmakers race to the finish line

7 years ago

With radiotherapy en vogue, Belgian startup nabs nearly $42M in Series A funding

7 years ago

Partnered with Novartis, tiny Cadent jumps out of stealth with $40M round for its CNS pipeline

7 years ago

First page Previous page 118 119 120121122 123 124 Next page Last page